Amoxicillin/metronidazole/omeprazole/clarithromycin: A new, short quadruple therapy for Helicobacter pylori eradication

Helicobacter

Volumn 3, Issue 1, 1998, Pages 54-58

  Treiber, G ^a   Ammon, S ^b   Schneider, E ^b   Klotz, U ^b  

^a ROBERT BOSCH HOSPITAL   (Germany)

^b DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIULCER AGENT; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; DRUG COMBINATION; DRUG EFFECT; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; MIDDLE AGED; PHASE 2 CLINICAL TRIAL; PILOT STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMOXICILLIN; ANTI-ULCER AGENTS; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; PILOT PROJECTS; PROSPECTIVE STUDIES;

EID: 0032012737     PISSN: 10834389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-5378.1998.08019.x     Document Type: Article

References (21)

1. Rauws AJ, van der Hulst WM. Current guidelines for the eradication of Helicobactcr pylori in peptic ulcer disease. Drugs 1995;50:984-90.
2. Dixon JS. Helicobactcr pylori eradication: Unravelling the facts. Scand J Gastroenterol 1995;212(Suppl 30):48-62.
3. Penston JG, McColl KEL. Eradication on Helicobacter pylori: an objective assessment of current therapies. Br J Clin Pharmacol 1997;43:223-43.
4. Treiber G. The influence of drug dosage on Helicobacter pylori eradication. A cost-effectiveness analysis. Am J Gastroenterol 1996;91:246-57.
5. Treiber G, Ammon S, Klotz U. Age dependent Helicobacter pylori eradication with dual therapy. Aliment Pharmacol Ther 1997;11:711-8.
6. Labenz J, Leverkus F, Borsch G. Omeprazole plus amoxicilllin for cure of Helicobacter pylori. Scand J Gastroenterol 1994;29:1070-5.
7. Graham DY, deBoer WA, Tytgat G. Choosing the best anti-Helicobacter pylori therapy: Effect of antimicrobial resistance. Am J Gastroenterol 1996;91:1072-6.
8. DeBoer WA, Driessen WMM, Tytgat GNJ. Only four days of quadruple therapy can effectively cure Helicobacter pylori infection. Aliment Phramacol Ther 1995;9:633-8.
9. DeBoer WA, van Etten RJXM, Schade RWB, et al. 4-day lansoprazole quadruple therapy: a highly effective cure for Helicobacter pylori infection. Am J Gastroenterol 1996;91:1778-82.
10. Malfertheimer P, Megraud F, O.'Morain C, et al. Current European concepts in the management of Helicobacter pylori infection: The Maastricht Consensus report. Eur J Gastroenterol Hepatol 1997;9:1-2.
11. Weissfeld A, Simmons D, Rose P, et al. Susceptibility of Helicobacter pylori to clarithromycin and amoxicillin in US. Gastroenterol 1997;112(Suppl): A329.
12. National Institute of Health. Consensus conference. Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65-9.
13. Labenz J, Borsch G. Highly significant change of the clinical course of Helicobacter pylori infection. Am J Gastroenterol 1994;89:1785-8.
14. Cover LC, Blaser MJ. Helicobacter pylori infection, a paradigm for chronic mucosal inflammation: Pathogenesis and implication for eradication and prevention. Adv Intern Med. 1996;41:85-117.
15. International Agency for Research on Cancer. Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum. 1994;61: 177-241.
16. Bazzoli F, Zagari RM, Fossi S, Pozzato P, Alampi G, Simoni P, Sottili S, Roda A, Roda E. Short-term, low-dose triple therapy for eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1994;6:773-7.
17. DeKoster E, Cozzbli A, Vandenborre C, et al. H. pylori resistance to macrolides increases, to imidazoles remains stable. Gastroenterol 1997;112 (Suppl):A99.
18. Tillenburg B, Siehoff S, Backer T et al. Helicobacter pylori: The situation of pretherapeutical resistance rates in Germany. Z Gastroenterol 1997;35:165-9.
19. Megraud F, Lehn N, Lind T, et al. The MACH 2 study. Helicobacter pylori resistance to antimicrobial agents and its influence on clinical outcome. Gastroenterol 1997;112(Suppl):A216.
20. Lee JM, Fallon C, Breslin NP, et al. H. pylori eradication: 'quadruple therapy' is effective in 'triple therapy' failures. Gastroenterol 1997;112(Suppl): A195.
21. Schepp W. Omeprazol + Clarithromycin + Metronidazol Neuer Standard für die Eradikation von Helicobacter pylori (review). Z Gastroenterol 1995;33:621-3.